Harward University launched a startup https://www.i2obio.com/ that going to keep away the syringes in the near future. Injections are given in the form of pills to the patients. An innovative technology developed by Harvard University promises there is no more pain to take medicines.
Many medicines are given via injection rather than pills, there were no other ways to have those effective therapeutics.
This patient-friendly treatment is safer and more effective. Medicines that are restricted to give orally are now can take in the form of pills and eases the treatment burden. The startup raised $4M in seed funding from Sanofi Ventures and the JDRF T1D Fund to commercialize the technology at the clinical level.
Our technology has the potential to enable the oral delivery of high-value drugs in a safer, more effective and patient-friendly way and also by easing the treatment burden for dozens of therapeutics that were previously restricted to intravenous or subcutaneous delivery,” said Mitragotri, Hiller Professor of Bioengineering and Hansjorg Wyss Professor of Biologically Inspired Engineering
